Crossmark

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Crossref DOI link: https://doi.org/10.1186/s12885-018-5254-0

Published Online: 2019-01-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kriegsmann, Mark https://orcid.org/0000-0002-7319-3646
Roessler, Stephanie

Kriegsmann, Katharina

Renner, Marcus

Longuespée, Rémi

Albrecht, Thomas

Loeffler, Moritz

Singer, Stephan

Mehrabi, Arianeb

Vogel, Monika Nadja

Pathil, Anita

Köhler, Bruno

Springfeld, Christoph

Rupp, Christian

Weiss, Karl Heinz

Goeppert, Benjamin
License Information

Text and Data Mining valid from 2019-01-15
More Information

Article History

Received: 13 June 2018

Accepted: 26 December 2018

First Online: 15 January 2019

Ethics approval and consent to participate

: Tissues were used in accordance with the ethical regulations of the NCT tissue bank established by the local ethics committee (S-207/2015). Ethics approval, written and verbal consent to participate has been given by all participants.

: Consent for publication has been obtained (NCT; project # 2116 and S-207/2015).

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.